Related Experiment Video
Updated: Oct 28, 2025

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
[Non-Hodgkin cardiac lymphomas]
I Tazi1, A Benmoussa1, F Z Boufarissi1
1Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc.
Insights
Cardiac non-Hodgkin lymphoma (CNHL) is a rare heart cancer. Early diagnosis via imaging and tissue analysis, followed by chemotherapy and radiotherapy, is crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Oncology
- Hematology
Background:
- Cardiac non-Hodgkin lymphoma (CNHL) is a rare extranodal lymphoma with a poor prognosis.
- Secondary cardiac lymphoma is more common than primary cardiac lymphoma, frequently involving the right heart.
- Diffuse B-cell lymphoma constitutes the majority of CNHL cases.
Purpose of the Study:
- To summarize the key aspects of cardiac non-Hodgkin lymphoma.
- To highlight diagnostic modalities and treatment strategies for CNHL.
Main Methods:
- Review of existing literature on cardiac non-Hodgkin lymphoma.
- Discussion of diagnostic tools such as echocardiography, MRI, and tissue biopsy.
- Outline of treatment approaches including chemotherapy and radiotherapy.
Main Results:
- CNHL diagnosis can be suggested by echocardiography and MRI.
- Cytological examination of pericardial fluid or histological analysis of cardiac tissue is essential for definitive diagnosis.
- Prompt diagnosis and early, individualized treatment are critical.
Conclusions:
- Effective management of CNHL requires a multidisciplinary approach.
- Chemotherapy, often containing anthracycline, combined with radiotherapy, represents the most effective treatment.
- Early intervention is paramount for improving outcomes in cardiac non-Hodgkin lymphoma.
Abstract:
Cardiac non-Hodgkin lymphoma (CNHL) is a rare extranodal lymphoma with a poor prognosis. Secondary cardiac lymphoma is more frequent than primary cardiac lymphoma. CNHL often involves the right side of the heart. Diagnosis of CNHL can be suggested by echocardiography and magnetic resonance imaging. Cytological examination of pericardial fluid or histological of cardiac tissue is essential. The majority of cases are diffuse B-cell lymphoma. A prompt immediate diagnosis and early treatment are essential for better outcome. Management should be individualized and the most effective treatment is chemotherapy containing anthracycline variably combined with radiotherapy. A multidisciplinary approach is essential to the successful treatment of CNHL.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy I: Introduction and Classification
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Cardiomyopathy IV: Restrictive Cardiomyopathy

